Expression of tumor suppressive microRNA‐34a is associated with a reduced risk of bladder cancer recurrence
Open Access
- 29 December 2014
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 137 (5) , 1158-1166
Abstract
Bladder cancer is the fourth most common cancer among men in the United States and more than half of patients experience recurrences within 5 years after initial diagnosis. Additional clinically informative and actionable biomarkers of the recurrent bladder cancer phenotypes are needed to improve screening and molecular therapeutic approaches for recurrence prevention. MicroRNA‐34a (miR‐34a) is a short noncoding regulatory RNA with tumor suppressive attributes. We leveraged our unique, large, population‐based prognostic study of bladder cancer in New Hampshire, United States to evaluate miR‐34a expression levels in individual tumor cells to assess prognostic value. We collected detailed exposure and medical history data, as well as tumor tissue specimens from bladder patients and followed them long‐term for recurrence, progression and survival. Fluorescence‐based in situ hybridization assays were performed on urothelial carcinoma tissue specimens (n = 229). A larger proportion of the nonmuscle invasive tumors had high levels of miR‐34a within the carcinoma cells compared to those tumors that were muscle invasive. Patients with high miR‐34a levels in their baseline nonmuscle invasive tumors experienced lower risks of recurrence (adjusted hazard ratio 0.57, 95% confidence interval 0.34–0.93). Consistent with these observations, we demonstrated a functional tumor suppressive role for miR‐34a in cultured urothelial cells, including reduced matrigel invasion and growth in soft agar. Our results highlight the need for further clinical studies of miR‐34a as a guide for recurrence screening and as a possible candidate therapeutic target in the bladder.Keywords
Funding Information
- National Institutes of Health (R21 CA182659)
This publication has 47 references indexed in Scilit:
- MicroRNAs in Stress Signaling and Human DiseaseCell, 2012
- Capture of MicroRNA–Bound mRNAs Identifies the Tumor Suppressor miR-34a as a Regulator of Growth Factor SignalingPLOS Genetics, 2011
- Identification of Methylated Genes Associated with Aggressive Bladder CancerPLOS ONE, 2010
- Fluorescence-Based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid TumorsClinical Cancer Research, 2010
- MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressorsJournal of Clinical Investigation, 2010
- miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancerBritish Journal of Cancer, 2010
- Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder CancerCancer Research, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Histological classification and stage of newly diagnosed bladder cancer in a population-based study from the Northeastern United StatesScandinavian Journal of Urology and Nephrology, 2008
- A microRNA component of the p53 tumour suppressor networkNature, 2007